Steady-State Transcript Levels of the Porphobilinogen Deaminase Gene in Patients with Acute Intermittent Porphyria

Genome Research

Volumn 7, Issue 11, 1997, Pages 1054-1060

  Mustajoki, Sami ^a   Kauppinen, Raili ^a   Mustajoki, Pertti ^a   Suomalainen, Anu ^b   Peltonen, Leena ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PORPHOBILINOGEN DEAMINASE; PRIMER DNA;

ACUTE INTERMITTENT PORPHYRIA; ALLELE; ARTICLE; BIOSYNTHESIS; CODON; ENZYMOLOGY; EXON; FRAMESHIFT MUTATION; GENE DELETION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LEUKOCYTE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION;

ALLELES; BASE SEQUENCE; CODON; DNA PRIMERS; EXONS; FRAMESHIFT MUTATION; HUMANS; HYDROXYMETHYLBILANE SYNTHASE; LEUKOCYTES; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION; PORPHYRIA, ACUTE INTERMITTENT; RNA, MESSENGER; SEQUENCE DELETION; TRANSCRIPTION, GENETIC;

EID: 0031265411     PISSN: 10889051     EISSN: None     Source Type: Journal    
DOI: 10.1101/gr.7.11.1054     Document Type: Article

References (24)

1. Anderson, P.M., R.M. Reddy, K.E. Anderson, and R.J. Desnick. 1981. Characterization of the porphobilinogen deaminase deficiency in acute intermittent porphyria. J. Clin. Invest. 68: 1-12.
2. Carter, M.S., S. Li, and M.F. Wilkinson. 1996. A splicing-dependent regulatory mechanism that detects translation signal. EMBO J. 15: 5965-5975.
3. Chirgwin, J.M., A.E. Przbyla, R.J. McDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299.
4. Chretien, S., A. Dubart, D. Beaupain, A. Raich, B. Grandchamp, J. Rosa, M. Goossens, and P.M. Romeo. 1988. Alternative transcription and splicing of the human porphobilinogen deaminase results either in tissue-specific or in house-keeping expression. Proc. Natl. Acad. Sci. 85: 6-9.
5. Cooper, D.N. 1993. Human gene mutations affecting RNA processing and translation. Ann. Med. 25: 11-17.
6. Deybach, J.-C. and H. Puy. 1995. Porphobilinogen deaminase gene structure and molecular defects. J. Bioenerg. Biomembr. 27: 197-205.
7. Grandchamp, B., H. de Verneuil, C. Beaumont, S. Chretien, O. Walter, and Y. Nordmann. 1987. Tissue-specific expression of porphobilinogen deaminase: Two isoenzymes from a single gene. Eur. J. Biochem. 162: 105-110.
8. Higuchi, R. 1989. Simple and rapid preparation of samples for PCR. In PCR technology. Principles and applications for DNA amplification (ed. H.A. Ehrlich), pp. 31-38. Stockton Press, New York, NY.
9. Kappas, A., S. Sassa, R.A. Galbraith, and Y. Nordmann. 1995. The porphyrias. In The metabolic and molecular buses of inherited diseases (ed. C.R. Scriver, A. Beaudet, W.S. Sly, and D. Valle), pp. 2116-2127. McGraw-Hill, New York, NY.
10. Karttunen, L., L. Lönnqvist, M. Godfrey, L. Peltonen, and A.-C. Syvänen. 1996. An accurate method for comparing transcript of two alleles or highly homologous genes: Application to fibrillin transcripts in Marfan patients' fibroblasts. Genome Res. 6: 392-403.
11. Kauppinen, R. and P. Mustajoki. 1992. Prognosis of acute intermittent porphyria: Occurrence of acute attacks, precipitating factors and associated disease. Medicine 71: 1-13.
12. Kauppinen, R., L. Peltonen, H. Pihlaja, and P. Mustajoki. 1992. CRIM-positive mutations of acute intermittent porphyria in Finland. Hum. Mutat. 1: 392-396.
13. Kauppinen, R., S. Mustajoki, H. Pihlaja, L. Peltonen, and P. Mustajoki. 1995. Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene. Hum. Mol. Genet. 4: 215-222.
14. Lee, J. 1991. "Molecular genetic investigation of the human porphobilinogen deaminase gene in acute intermittent porphyria." PhD thesis, Karolinska Instituted Reproprint, Stockholm, Sweden.
15. Mullis, K.B. and F. Faloona. 1987. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 155: 335-350.
16. Mustafa, S., I. Pabinger, and C. Mannhalter. 1995. Protein S deficiency type I: Identification of point mutations in 9 of 10 families. Blood 86: 3444-3451.
17. Mustajoki, P. and R.J. Desnick. 1985. Genetic heterogeneity in acute intermittent porphyria: Characterization and frequency of porphobilinogen deaminase in Finland. Br. Med. J. 291: 505-509.
18. Namba, H., K. Narahara, K. Tsuji, Y. Yokoyama, and Y. Seino. 1991. Assignment of human porphobilinogen deaminase to 11q24.1-q24.2 by in situ hybridization and gene dosage studies. Cytogenet. Cell. Genet. 57: 105-108.
19. Ploos van Amstel, J.K, A.J.I.W. Bergman, E.A.C.M. van Beurden, J.F.M. Roijers, T. Peelen, I.E.T. van der Berg, B.T. Poll-The, E.A. Kvittingen, and R. Berger. 1996. Hereditary tyrosinemia type 1: Novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene variability of the genotype-phenotype relationship. Hum. Genet. 97: 51-59.
20. Raich, N., P.M. Romeo, A. Dubart, D. Beaupain, M. Cohen-Solal, and M. Goossens. 1986. Molecular cloning and complete primary sequence of human erythrocyte PBG deaminase. Nucleic Acids Res. 14: 5955-5968.
21. Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59: 423-450.
22. _. 1996. Control of messenger RNA stability in higher eukaryotes. Trends Genet. 12: 171-175.
23. Syvänen, A.-C., K. Aalto-Setälä, L. Harju, K. Kontula, and H. Söderlund. 1990. A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics 8: 684-692.
24. Syvänen, A.-C., A. Sajantila, and M. Lukka. 1993. Identification of individuals by analysis of biallelic DNA markers using PCR and solid-phase minisequencing. Am. J. Hum. Genet. 52: 46-59.